Subcutaneous Immunoglobulin Effective for Maintenance in CIDP Subcutaneous Immunoglobulin Effective for Maintenance in CIDP

Subcutaneous immunoglobulin is effective and convenient maintenance therapy for chronic inflammatory demyelinating polyneuropathy, the PATH trial has shown. Local reactions decreased with repeat dosing.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news